相关实验视频

Updated: Jul 4, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

击中和逃跑的疫苗系统克服了有限的新抗原表征,以获得有效的广泛抗瘤反应

Hongyu Chen¹, Zichao Huang¹, Jiaxuan Li²

¹School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, China; Key laboratory of Polymer Ecomaterials, Changchun Institue of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.

Science bulletin

|February 8, 2024

概括

这项研究引入了一种新的"击中逃跑"癌症疫苗策略. 这种方法有效地向具有低突变负担的瘤,通过用新抗原装饰癌细胞,增强T细胞反应以改善癌症治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
纳米技术纳米技术
生物医学工程生物医学工程

背景情况:

新抗原癌症疫苗有前途,但在突变负担较低的瘤中是有限的.
为这些具有挑战性的瘤类型开发有效的癌症疗法仍然是一个至关重要的未满足需求.

研究的目的:

提出和验证一种"撞击逃跑"疫苗策略,用于治疗具有较低瘤突变负担的瘤.
为了证明一种类纳米疫苗系统的有效性,该系统可以引起T细胞对装饰着外源性新抗原的瘤细胞的反应.

主要方法:

采用一种基于聚2-zoline (POx) 的纳米载体与OVA257-264通过MMP-2敏感链接器结合,用于瘤细胞装饰.
开发了一种基于POx的纳米疫苗,含有OVA257-264,可诱导OVA特异性T细胞反应.
在临床前模型中评估了联合"撞击逃跑"疫苗系统的治疗有效性.

主要成果:

使用POx-纳米载体系统证明了瘤细胞在体内高效和选择性的OVA的装饰.
使用设计的纳米疫苗成功引起了OVA特异性T细胞反应.
在各种瘤类型中展示了有效的疫苗疗法,包括缺乏内源性OVA抗原表达的瘤类型.

结论:

"撞击逃跑"疫苗策略为癌症治疗提供了一个有希望和统一的方法,特别是在具有低突变负担的瘤中.
这种新的纳米疫苗系统克服了传统新抗原疫苗的局限性,通过实现向抗原输送和T细胞原始化.

关键词:

癌症免疫疗法癌症免疫疗法癌症疫苗疫苗癌症疫苗纳米载体纳米载体是什么新抗原是一种新抗原.聚二氧化) 是一种聚二氧化.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations